HomeBUSINESS
BUSINESS

Bayer Yakuhin to Ban Any Type of Medical Affairs Work by Sales Organization
(Jul.18.2017)

Bayer Yakuhin on July 14 vowed to take a series of measures to beef up its governance in the wake of a scandal surrounding surveys related to its flagship anticoagulant Xarelto (rivaroxaban), including prohibiting its marketing and sales organization from doing any type of work in the medical affairs field ...
(LOG IN FOR FULL STORY)

News Calendar